三阴性乳腺癌两个新辅助化疗疗效比较
赵夷;胡婷嫣;于辉;李锦成
【期刊名称】《医学与哲学》 【年(卷),期】2014(000)016
【摘要】This article is to analyze the efficacy and adverse reactions of docetaxel and carboplatin as neoadjuvant chemotherapy for triple negative breast cancer (TNBC) .The clinical data of 84 cases of breast cancer was collected from March 2010 to September 2013 in the First Affiliated Hospital of Liaoning Medical College . The article analyzes the efficacy and adverse reactions from that docetaxel and carboplatin ( TP ) regimen compare with pirarubicin , cyclophosphamide ,5-fluorouracil (CAF) in neoadjuvant chemotherapy .TP group of patients with efficient (RR) is superior to CAF group ,P< 0 .05) .Two groups of adverse drug reactions
in
patients
with
no
significant
difference ,P>0 .05 .Combination of docetaxel and carboplatin as neoadjuvant chemotherapy for triple negative breast cancer has definite curative effect and good tolerance .%分析多西他赛联合卡铂方案在三阴性乳腺癌新辅助化疗中的疗效及不良反应。分析2010年03月～2013年09月我院收治的84例TNBC患者临床资料，分析对比多西他赛联合卡铂（TP）方案与吡柔比星、氟尿嘧啶、环磷酰胺（CAF）方案新辅助化疗疗效及不良反应。TP组患者的有效率（RR）优于CAF组，P＜0．05。两组患者的药物不良反应无明显差异，P＞0．05。多西他赛联合卡铂方案用于三阴性乳腺癌新辅助化疗，
三阴性乳腺癌两个新辅助化疗疗效比较
